Detalles de la búsqueda
1.
Mortality in patients with psoriatic arthritis in Sweden: a nationwide, population-based cohort study.
Ann Rheum Dis
; 83(4): 446-456, 2024 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38049985
2.
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries.
Rheumatology (Oxford)
; 63(3): 751-764, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37314967
3.
Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?
J Rheumatol
; 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38621792
4.
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care.
J Rheumatol
; 51(4): 378-389, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38224992
5.
Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries.
Rheumatology (Oxford)
; 62(2): 647-658, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35723604
6.
How good is the agreement between clinical diagnoses and classification criteria fulfilment in axial spondyloarthritis? Results from the SPARTAKUS cohort.
Scand J Rheumatol
; 52(4): 364-373, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35695036
7.
Elevated fecal levels of the inflammatory biomarker calprotectin in early systemic sclerosis.
Rheumatol Int
; 43(5): 961-967, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36566433
8.
Mortality over 14 years in MTX-refractory patients randomized to a strategy of addition of infliximab or sulfasalazine and hydroxychloroquine.
Rheumatology (Oxford)
; 60(5): 2217-2222, 2021 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33179071
9.
Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis.
Rheumatology (Oxford)
; 60(8): 3635-3645, 2021 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33367900
10.
Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study.
Rheumatology (Oxford)
; 60(1): 140-146, 2021 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32591790
11.
Elevated faecal calprotectin is linked to worse disease status in axial spondyloarthritis: results from the SPARTAKUS cohort.
Rheumatology (Oxford)
; 58(7): 1176-1187, 2019 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30649509
12.
Work disability in non-radiographic axial spondyloarthritis patients before and after start of anti-TNF therapy: a population-based regional cohort study from southern Sweden.
Rheumatology (Oxford)
; 56(5): 716-724, 2017 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28064208
13.
Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota.
ACR Open Rheumatol
; 2024 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38653503
14.
Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network.
Arthritis Rheumatol
; 76(4): 587-598, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37975166
15.
The National Prevalence of Clinically Diagnosed Psoriatic Arthritis in Sweden in 2017.
J Rheumatol
; 50(6): 781-788, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36858434
16.
Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study.
RMD Open
; 9(2)2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37173095
17.
Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis.
Arthritis Res Ther
; 24(1): 42, 2022 02 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35151357
18.
One-Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses.
Arthritis Care Res (Hoboken)
; 74(5): 748-758, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33253491
19.
Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries.
Arthritis Care Res (Hoboken)
; 74(7): 1205-1218, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33460531
20.
Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration.
Semin Arthritis Rheum
; 56: 152081, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35985172